Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.
Cappellen
D
D
Laboratoire de Morphogenèse Cellulaire et Progression Tumorale, UMR 144, Centre National de la Recherche Scientifique, Institut Curie, Section de Recherche, 26 rue d'Ulm, 75248 Paris Cedex 05, France.
De Oliveira
C
C
Ricol
D
D
de Medina
S
S
Bourdin
J
J
Sastre-Garau
X
X
Chopin
D
D
Thiery
J P
JP
Radvanyi
F
F
D001483:Base Sequence; D002584:Cervix Uteri / Q000378:metabolism; D004848:Epithelium / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation; D020125:Mutation, Missense; D017354:Point Mutation; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics*; D014178:Translocation, Genetic; D001743:Urinary Bladder / Q000378:metabolism; D001749:Urinary Bladder Neoplasms / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000235:genetics*
D017468:Receptors, Fibroblast Growth Factor; C496365:FGFR3 protein, human; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3